Candido Hernandez - Global Med Affairs, Gilead Sci

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 31 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

WED-482 Local Elimination Programs Leading to Global Action in HCV (LEGA-C): Implementation Science Studies in Europe Aiming to Streamline the HCV Care Pathway

Candido Hernández, Julian Elrayes,Marinela Mendez,Francesca Frigerio,Louise Missen, Audrey Le Blevec,Mehtap Guendogdu, K. Kwon,Stacey Scherbakovsky,Kim Vanstraelen,Bruce Kreter

Journal of hepatology (2024): S681-S682

Cited0Views0Bibtex

ReLink Strategy in Diagnosed-but-untreated Hepatitis C-positive Patients in Germany: Report from a Single Center

Sarah Lange, Christina Baehr, Nur Irem Cakman-Hinrichs, Katharina Cron, Hannah Fengels, Christina Gregor, Katrin Matschenz, Jorg Petersen, Robin Steinfurth,Albrecht Stoehr, Stefan Unger, Maria Gil Mir,Candido Hernandez, Marianna Schwenken,Peter Buggisch

Zeitschrift fur Gastroenterologieno. 10 (2024): 1701-1707

Cited0Views0WOSBibtex

THU-374 Description of Age, Sex, and Characteristics of Hepatitis C Patients in the SVR10 K Study: a Real-World SOF/VEL Analysis Performed Across Five Global Regions

Soo Aleman,Fátima Higuera-de la Tijera,Francisco Javier Garcia-Samaniego,Marta Casado-Martín,Grace Lai‐Hung Wong, M. Alzaabi,Habiba Kamal,Katarina Lindahl,Aastha Chandak,Marta Martínez,Artak Khachatryan,Linda Chen,Candido Hernández,Kim Vanstraelen, Ming‐Lung Yu

Journal of hepatology (2024): S836-S836

Cited0Views0Bibtex

The Tolerability of Sofosbuvir/velpatasvir for 12 Weeks in Patients Treated in the ASTRAL 1, 2 and 3 Studies: A Pooled Safety Analysis

Ira M. Jacobson,Stefan Bourgeois,Phillipe Mathurin,Paul Thuluvath,Stephen D. Ryder,Guido Gerken,Candido Hernandez,Kim Vanstraelen,Stacey Scherbakovsky,Anu Osinusi,Dana Tedesco,Graham R. Foster

Journal of viral hepatitis（2023）

Cited0Views0WOSBibtex

Changing HCV Patient Profiles: Insights from a Large Multinational Real-World Sofosbuvir/velpatasvir (SOF/VEL) Dataset

Zeitschrift für Gastroenterologie（2023）

Cited0Views0Bibtex

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis

Steven Flamm,Eric Lawitz,Brian Borg,Michael Charlton,Charles Landis,K. Rajender Reddy,Mitchell Shiffman,Angel Alsina,Charissa Chang,Natarajan Ravendhran,Candido Hernandez,Christophe Hezode,Stacey Scherbakovsky,Renee-Claude Mercier,Didier Samuel

Viruses（2023）

Cited0Views0WOSBibtex

Concomitant Use of Proton Pump Inhibitors and Sofosbuvir/Velpatasvir: Evidence from Randomized Clinical Trials and Real-World Data

Rafael Esteban,Steve Flamm,Maria Buti,Juan Turnes,Liyun Ni,Candido Hernandez,Alessandra Mangia

Journal of hepatology (2023): S1209-S1209

Cited0Views0Bibtex

Use of Psychiatric Medication and Drug Interactions in Patients with Hcv Infection Treated with Pangenotypic Direct-Acting Antivirals

J. Turnes,A. Garcia-Herola, R. M. Verdugo,M. Mendez,C. De Alvaro,C. Hernandez,A. Sicras-Mainar

Digestive and Liver Disease/Digestive and liver disease（2023）

Cited0Views0Bibtex

IMPACT OF POLYPHARMACY AND AGING ON THE RISK OF MULTIPLE DRUG-DRUG INTERACTIONS (DDIS) IN HCV PATIENTS TREATED WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS (PDAA)

Stefano Fagiuoli,Pierluigi Toniutto,Nicola Coppola,Domenica Daniela Ancona,Margherita Andretta,Fausto Bartolini,Fulvio Ferrante,Alessandro Lupi,Stefano Palcic,Francesca Vittoria Rizzi,Davide Re,Gema Alvarez Nieto,Candido Hernandez,Francesca Frigerio,Valentina Perrone, Luca Degli Esposti,Alessandra Mangia

THERAPEUTICS AND CLINICAL RISK MANAGEMENT（2023）

Cited2Views0WOSBibtex

Analysis of Patients' Characteristics and Treatment Profile of People Who Use Drugs (pwuds) with and Without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis

Felice Alfonso Nava,Alessandra Mangia,Marco Riglietta,Lorenzo Somaini,Francesco Giuseppe Foschi,Ernesto Claar,Ivana Maida,Claudio Ucciferri,Francesca Frigerio,Candido Hernandez,Melania Dovizio,Valentina Perrone, Luca Degli Esposti,Massimo Puoti

Therapeutics and clinical risk management（2023）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn